During the past decade, John Buhler Research Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "John Buhler Research Center" #1 collaborator was "ViroChem Pharma" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "John Buhler Research Center" are "Chronic Hepatitis C" (1 trials), "Chronic Hepatitis C Infection" (1 trials), "Chronic Idiopathic Constipation" (1 trials) and "Hepatitis C" (1 trials). Many other conditions were trialed in "John Buhler Research Center" in a lesser frequency.

Most popular intervention types in "John Buhler Research Center" are "Drug" (4 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Copegus®" (1 trials), "Elobixibat 10 mg" (1 trials), "Elobixibat 5 mg" (1 trials), "GS-9190" (1 trials) and "GS-9190 placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "John Buhler Research Center" are 4 trials for "All" genders.

Currently, there are NaN active trials in "John Buhler Research Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in John Buhler Research Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in John Buhler Research Center, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".